Related references
Note: Only part of the references are listed.Toll-like receptors 2 and 4 stress signaling and sodium-glucose cotransporter-2 in kidney disease
Vishwadeep Shelke et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2023)
Phloretin inhibits glucose transport and reduces inflammation in human retinal pigment epithelial cells
Maria Hytti et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2023)
Evaluating the potential of tauroursodeoxycholic acid as add-on therapy in amelioration of streptozotocin-induced diabetic kidney disease
Himanshu Sankrityayan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2023)
Renin-angiotensin-aldosterone pathway modulators in chronic kidney disease: A comparative review
Saeed Alshahrani
FRONTIERS IN PHARMACOLOGY (2023)
Tetrahydrocurcumin Add-On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury
Mahyar Khazaeli et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2023)
Transcriptomic evidence of hypothalamus for maternal fructose exposure induced offspring hypertension through AT1R/TLR4 pathway
Qing Guo et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2023)
Epigenetic restoration of endogenous Klotho expression alleviates acute kidney injury-diabetes comorbidity
Ajinath Kale et al.
LIFE SCIENCES (2022)
Toll-like receptor 4 mutation protects the kidney from Ang-II-induced hypertensive injury
Suravi Majumder et al.
PHARMACOLOGICAL RESEARCH (2022)
Oleic acid alleviates LPS-induced acute kidney injury by restraining inflammation and oxidative stress via the Ras/MAPKs/PPAR-γ signaling pathway
Beibei Zhang et al.
PHYTOMEDICINE (2022)
Epigenetic regulation of Toll-like receptors 2 and 4 in kidney disease
Vishwadeep Shelke et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2022)
Metformin Is Associated with the Inhibition of Renal Artery AT1R/ET-1/iNOS Axis in a Rat Model of Diabetic Nephropathy with Suppression of Inflammation and Oxidative Stress and Kidney Injury
Amal F. Dawood et al.
BIOMEDICINES (2022)
Losartan attenuates sepsis-induced cardiomyopathy by regulating macrophage polarization via TLR4-mediated NF-κB and MAPK signaling
Xin-Sen Chen et al.
PHARMACOLOGICAL RESEARCH (2022)
Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives
Daniela Maria Tanase et al.
BIOMOLECULES (2022)
Klotho restoration via ACE2 activation: A potential therapeutic strategy against acute kidney injury-diabetes comorbidity
Ajinath Kale et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2022)
Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus
Jana Blahova et al.
PHARMACEUTICALS (2021)
Renin-angiotensin system blockade in patients with chronic kidney disease: benefits, problems in everyday clinical use, and open questions for advanced renal dysfunction
Charalampos Loutradis et al.
JOURNAL OF HUMAN HYPERTENSION (2021)
TLR4 and AT1R mediate blood-brain barrier disruption, neuroinflammation, and autonomic dysfunction in spontaneously hypertensive rats
Francesca E. Mowry et al.
PHARMACOLOGICAL RESEARCH (2021)
Multifaceted roles of Toll-like receptors in acute kidney injury
Rakhshinda Habib
HELIYON (2021)
US Trends in Hospitalizations for Dialysis-Requiring Acute Kidney Injury in People With Versus Without Diabetes
Jessica Lee Harding et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
The Interplay of Renin-Angiotensin System and Toll-Like Receptor 4 in the Inflammation of Diabetic Nephropathy
Qi Feng et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Evidence for a Physiological Mitochondrial Angiotensin II System in the Kidney Proximal Tubules Novel Roles of Mitochondrial Ang II/AT1a/O2-and Ang II/AT2/NO Signaling
Xiao Chun Li et al.
HYPERTENSION (2020)
Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations
Giovanna Leoncini et al.
JOURNAL OF NEPHROLOGY (2020)
Acute Kidney Injury: A Bona Fide Complication of Diabetes
Andrew Advani
DIABETES (2020)
Effects of renal ischemia injury on brain in diabetic and non-diabetic rats: Role of angiotensin II type 2 receptor and angiotensin-converting enzyme 2
Nisha Sharma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Fiend and friend in the renin angiotensin system: An insight on acute kidney injury
Nisha Sharma et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis
Ki Wung Chung et al.
CELL METABOLISM (2019)
Angiotensin 1 receptor antagonist attenuates acute kidney injury-induced cognitive impairment and synaptic plasticity via modulating hippocampal oxidative stress
Fatemeh Sharifi et al.
LIFE SCIENCES (2019)
Angiotensin II type 2 receptor and angiotensin-converting enzyme 2 mediate ischemic renal injury in diabetic and non-diabetic rats
Nisha Sharma et al.
LIFE SCIENCES (2019)
Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury
Jean-Christophe Wyss et al.
FRONTIERS IN PHARMACOLOGY (2019)
AT1 and AT2 receptors modulate renal tubular cell necroptosis in angiotensin II-infused renal injury mice
Yongjun Zhu et al.
SCIENTIFIC REPORTS (2019)
Diabetes aggravates renal ischemia-reperfusion injury by repressing mitochondrial function and PINK1/Parkin-mediated mitophagy
Yuan-Yuan Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Phloretin either alone or in combination with duloxetine alleviates the STZ-induced diabetic neuropathy in rats
Mohamed Balaha et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Angiotensin II enhances the acetylation and release of HMGB1 in RAW264.7 macrophage
Shanshan Zhou et al.
CELL BIOLOGY INTERNATIONAL (2018)
A randomised controlled trial evaluating renal protective effects of selenium with vitamins A, C, E, verapamil, and losartan against extracorporeal shockwave lithotripsy-induced renal injury
Ahmed R. El-Nahas et al.
BJU INTERNATIONAL (2017)
Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study
Cengiz Kocak et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)
Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury
Shun-Yang Cheng et al.
SCIENTIFIC REPORTS (2016)
Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
Sandesh Madhukar Bharati et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2016)
Angiotensin II-induced hypertensive renal inflammation is mediated through HMGB1-TLR4 signaling in rat tubulo-epithelial cells
Anand R. Nair et al.
EXPERIMENTAL CELL RESEARCH (2015)
Toll-Like Receptor Signaling Induces Nrf2 Pathway Activation through p62-Triggered Keap1 Degradation
Shasha Yin et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
Marsha A. Raebel
CARDIOVASCULAR THERAPEUTICS (2012)